vs
Side-by-side financial comparison of FRANKLIN STREET PROPERTIES CORP (FSP) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $26.0M, roughly 1.8× FRANKLIN STREET PROPERTIES CORP). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -28.1%, a 23.4% gap on every dollar of revenue. On growth, FRANKLIN STREET PROPERTIES CORP posted the faster year-over-year revenue change (-8.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-12.7M). Over the past eight quarters, FRANKLIN STREET PROPERTIES CORP's revenue compounded faster (-8.7% CAGR vs -20.2%).
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
FSP vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.0M | $47.7M |
| Net Profit | $-7.3M | $-2.3M |
| Gross Margin | 59.4% | — |
| Operating Margin | -27.9% | 14.3% |
| Net Margin | -28.1% | -4.8% |
| Revenue YoY | -8.2% | -47.3% |
| Net Profit YoY | 14.1% | -200.9% |
| EPS (diluted) | $-0.06 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.0M | $47.7M | ||
| Q3 25 | $27.3M | $122.1M | ||
| Q2 25 | $26.7M | $85.2M | ||
| Q1 25 | $27.1M | $41.1M | ||
| Q4 24 | $28.4M | $90.5M | ||
| Q3 24 | $29.7M | $91.6M | ||
| Q2 24 | $30.8M | $94.4M | ||
| Q1 24 | $31.2M | $74.9M |
| Q4 25 | $-7.3M | $-2.3M | ||
| Q3 25 | $-8.3M | $40.1M | ||
| Q2 25 | $-7.9M | $23.6M | ||
| Q1 25 | $-21.4M | $-37.4M | ||
| Q4 24 | $-8.5M | $2.3M | ||
| Q3 24 | $-15.6M | $3.6M | ||
| Q2 24 | $-21.0M | $-860.0K | ||
| Q1 24 | $-7.6M | $-4.2M |
| Q4 25 | 59.4% | — | ||
| Q3 25 | 60.9% | — | ||
| Q2 25 | 59.9% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 59.7% | — | ||
| Q3 24 | 61.0% | — | ||
| Q2 24 | 64.2% | — | ||
| Q1 24 | 64.7% | — |
| Q4 25 | -27.9% | 14.3% | ||
| Q3 25 | -30.5% | 61.8% | ||
| Q2 25 | -29.2% | 53.2% | ||
| Q1 25 | -78.9% | -70.7% | ||
| Q4 24 | -29.9% | 34.8% | ||
| Q3 24 | -52.4% | 28.0% | ||
| Q2 24 | -68.0% | 26.5% | ||
| Q1 24 | -24.0% | 14.7% |
| Q4 25 | -28.1% | -4.8% | ||
| Q3 25 | -30.5% | 32.8% | ||
| Q2 25 | -29.5% | 27.7% | ||
| Q1 25 | -79.1% | -90.9% | ||
| Q4 24 | -30.0% | 2.5% | ||
| Q3 24 | -52.6% | 4.0% | ||
| Q2 24 | -68.2% | -0.9% | ||
| Q1 24 | -24.2% | -5.6% |
| Q4 25 | $-0.06 | $0.01 | ||
| Q3 25 | $-0.08 | $0.23 | ||
| Q2 25 | $-0.08 | $0.14 | ||
| Q1 25 | $-0.21 | $-0.23 | ||
| Q4 24 | $-0.09 | $0.03 | ||
| Q3 24 | $-0.15 | $0.02 | ||
| Q2 24 | $-0.20 | $-0.01 | ||
| Q1 24 | $-0.07 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.6M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $607.0M | $-261.8M |
| Total Assets | $892.9M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.6M | $215.5M | ||
| Q3 25 | $31.4M | $140.4M | ||
| Q2 25 | $29.4M | $92.9M | ||
| Q1 25 | $30.2M | $108.5M | ||
| Q4 24 | $41.1M | $88.6M | ||
| Q3 24 | $40.9M | $88.2M | ||
| Q2 24 | $30.2M | $105.5M | ||
| Q1 24 | $34.2M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $607.0M | $-261.8M | ||
| Q3 25 | $615.3M | $-264.2M | ||
| Q2 25 | $624.7M | $-308.2M | ||
| Q1 25 | $633.4M | $-334.1M | ||
| Q4 24 | $655.9M | $-301.3M | ||
| Q3 24 | $665.4M | $-311.3M | ||
| Q2 24 | $682.1M | $-321.7M | ||
| Q1 24 | $703.9M | $-330.5M |
| Q4 25 | $892.9M | $396.9M | ||
| Q3 25 | $901.0M | $396.1M | ||
| Q2 25 | $903.2M | $342.9M | ||
| Q1 25 | $916.4M | $327.2M | ||
| Q4 24 | $946.9M | $350.9M | ||
| Q3 24 | $981.5M | $389.5M | ||
| Q2 24 | $1.0B | $395.6M | ||
| Q1 24 | $1.0B | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.8M | $74.6M |
| Free Cash FlowOCF − Capex | $-12.7M | $74.6M |
| FCF MarginFCF / Revenue | -48.6% | 156.3% |
| Capex IntensityCapex / Revenue | 63.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.3M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | $74.6M | ||
| Q3 25 | $8.3M | $47.6M | ||
| Q2 25 | $-2.9M | $-15.1M | ||
| Q1 25 | $-5.5M | $20.0M | ||
| Q4 24 | $9.0M | $15.2M | ||
| Q3 24 | $14.5M | $9.9M | ||
| Q2 24 | $-648.0K | $33.5M | ||
| Q1 24 | $-7.1M | $45.0M |
| Q4 25 | $-12.7M | $74.6M | ||
| Q3 25 | $3.0M | $47.6M | ||
| Q2 25 | $-5.7M | $-15.1M | ||
| Q1 25 | $-9.9M | $19.9M | ||
| Q4 24 | $-16.2M | — | ||
| Q3 24 | $8.6M | $9.9M | ||
| Q2 24 | $-5.1M | $33.4M | ||
| Q1 24 | $-15.8M | $44.9M |
| Q4 25 | -48.6% | 156.3% | ||
| Q3 25 | 11.0% | 39.0% | ||
| Q2 25 | -21.5% | -17.7% | ||
| Q1 25 | -36.7% | 48.4% | ||
| Q4 24 | -57.2% | — | ||
| Q3 24 | 29.1% | 10.8% | ||
| Q2 24 | -16.7% | 35.4% | ||
| Q1 24 | -50.8% | 60.0% |
| Q4 25 | 63.0% | 0.0% | ||
| Q3 25 | 19.4% | 0.0% | ||
| Q2 25 | 10.7% | 0.0% | ||
| Q1 25 | 16.4% | 0.1% | ||
| Q4 24 | 88.9% | 0.0% | ||
| Q3 24 | 19.6% | 0.0% | ||
| Q2 24 | 14.6% | 0.1% | ||
| Q1 24 | 28.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
